In previous studies in human subjects and mice with pulmonary hypertension, SPARC was shown to be overexpressed in lungs, and SPARC suppression using adenovirus vector attenuated cardiac and hemodynamic disorders [24]. The gene discussed is SPARC; the disease is pulmonary hypertension.